Gallery
Photos from events, contest for the best costume, videos from master classes.
 |  |
 |  |
 |  |
 |  |
 |  |
 |  |
The most recent Recall Enforcement Report that covers this product was initiated on July 31st, 2024 and classified as a Class II recall due to presence of foreign tablets; 3 fused tablets of metformin er 500 mg were found in bottle of gabapentin tablets This recall is currently terminated, and the associated recall number is recall number is D-0634-2024. It pertains to Gabapentin identified by Neurontin is an anticonvulsant drug used to treat partial seizures and nervous system pain. Some serious side effects have been reported. These include respiratory disease, allergic reactions, and suicidal thoughts. There were lawsuits filed against the drug companies behind Neurontin for trying to get doctors to prescribe the medication for unapproved uses. Health care and insurance providers Discover Gabapentin lawsuits information, including side effects, settlement claims, and lawsuit updates, to understand neurological damage, seizures, and addiction risks associated with the medication. Description: Gabapentin Tablets 600mg, 500-count bottles, Rx Only, Manufactured by: Glenmark Pharmaceuticals Limited, Pithampur, Madhya Pradesh 454775, India, Manufactured for: Glenmark Pharmaceuticals Inc. USA, Mahwah, NJ 07430. NDC# 68462-126-05. Mandated? Original Package? Consumers are filing lawsuits against prescription drug and medical device companies after facing serious injuries. Find out if you qualify for a lawsuit. Explore the potential for seeking compensation in gabapentin-related memory loss cases, including legal grounds, evidence, and filing deadlines. Gabapentin, a medication prescribed for nerve pain and seizures, is under scrutiny due to claims of memory loss linked to its use. Nearly 40 generic medications—most prescription, but some sold over-the-counter at Amazon and Walmart—have been recalled due to manufacturing quality concerns, the FDA said. See the full list Los Angeles, CA: A $325 million preliminary settlement has been reached by Pfizer Inc and Warner-Lambert Co. LLC and plaintiffs who filed a consumer fraud class action lawsuit over the marketing The Neurontin settlement marks the end to a nearly 10-year-old class action lawsuit battle in which plaintiffs, who included both direct purchasers and third-party payers, accused Pfizer of delaying generic versions of Neurontin and promoted the drug for unapproved uses. Recall Enforment Report D-0342-2025 Recall Details Multi event Drug Recall Enforcement Report Class II voluntary initiated by Glenmark Pharmaceuticals Inc., USA, originally initiated on 03-13-2025 for the product Diltiazem Hydrochloride Extended-Release Capsules 12HR 120mg, 100-count bottle, Rx, Only. Neurontin (generic name: gabapentin) was FDA-approved in 1993 for use as an anticonvulsant for people suffering from partial seizures associated with epilepsy. It is also FDA-approved for the The latest safety updates on drugs - including duloxetine recall, new warnings for gabapentin-type drugs, tetracycline new warnings, and more. The recall affects 13 728 bottles—12 876 bottles of 300 mg capsules and 852 bottles of 400 mg capsules—due to concerns of cross contamination during manufacturing. The impacted lots, with expiration dates ranging from March to August 2025, were distributed nationwide across the United States. Neurontin (gabapentin) lawsuits center around severe skin reactions including Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN). Plaintiffs allege that Pfizer failed to adequately warn patients and doctors about these potentially life-threatening risks. A Gabapentin lawsuit was filed in 2022, alleging that the manufacturers of Gabapentin failed to warn patients about the potential side effects of the medication, particularly memory loss. However, the overall benefits of Gabapentin in treating various conditions cannot be overlooked. The gabapentin lawsuit primarily stems from allegations of inadequate warnings regarding side effects. Plaintiffs claim that manufacturers did not sufficiently inform patients and healthcare providers about risks such as dizziness, sedation, and suicidal thoughts. The FDA has reported out that, Sun Pharmaceutical Industries, Inc. initiated a recall for 13,728 bottles of gabapentin, including 12,876 bottles containing 300-milligram dosage and 852 bottles containing 400 milligrams per dose. Description: Gabapentin Capsules, USP 400 mg, Rx Only, Packaged in a) 500-count bottles, NDC 62756-139-05; b) 1000-count bottles, NDC 62756-139-04; Distributed by: Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Industries Ltd. Halol-Baroda Highway, Halol-389 350, Gujarat, India. Several generic drugs were recalled over quality concerns; check lot numbers and talk to your pharmacist if your medication is affected.
Articles and news, personal stories, interviews with experts.
Photos from events, contest for the best costume, videos from master classes.
| |
| |
| |
| |
| |
| |